malondialdehyde has been researched along with shikonin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, H; Gan, L; Liu, T; Wang, T; Wang, Z; Yuan, X; Zhang, B; Zheng, Q | 1 |
| Gan, L; Liu, Y; Liu, YY; Si, J; Sun, C; Wang, ZG; Wang, ZH; Zhang, H; Zhou, R | 1 |
| Du, J; Guo, L; Li, W; Li, Y; Qiu, J; Wang, L; Zhang, T | 1 |
3 other study(ies) available for malondialdehyde and shikonin
| Article | Year |
|---|---|
Shikonin protects mouse brain against cerebral ischemia/reperfusion injury through its antioxidant activity.
Topics: Animals; Antioxidants; Biomarkers; Brain Ischemia; Dose-Response Relationship, Drug; Glutathione; Infarction, Middle Cerebral Artery; Male; Malondialdehyde; Mice; Mitochondria; Naphthoquinones; Neuroprotective Agents; Oxidative Stress; Oxidoreductases; Protein Carbonylation; Random Allocation; Reactive Oxygen Species; Reperfusion Injury; Up-Regulation | 2010 |
Protective effects of shikonin on brain injury induced by carbon ion beam irradiation in mice.
Topics: Animals; Antioxidants; Brain Injuries; Catalase; Heavy Ion Radiotherapy; Male; Malondialdehyde; Mice; Naphthoquinones; Protein Carbonylation; Radiation Injuries, Experimental; Radiation-Protective Agents; Random Allocation; Specific Pathogen-Free Organisms; Superoxide Dismutase | 2015 |
Shikonin ameliorates oxidative stress and neuroinflammation via the Akt/ERK/JNK/NF-κB signalling pathways in a model of Parkinson's disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Cyclooxygenase 2; Disease Models, Animal; Dopamine Plasma Membrane Transport Proteins; Glutathione; Interleukin-6; JNK Mitogen-Activated Protein Kinases; Malondialdehyde; Mice; Mice, Inbred C57BL; Naphthoquinones; Neuroinflammatory Diseases; Neurotoxins; NF-kappa B; Nitric Oxide Synthase Type II; Oxidative Stress; Parkinson Disease; Proto-Oncogene Proteins c-akt; Superoxide Dismutase; Tumor Necrosis Factor-alpha; Tyrosine 3-Monooxygenase | 2022 |